Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    The 10.000/μl Morning Trigger for Prophylactic Platelet Transfusion is Safe: Prospective Experience in 411 AML Patients

    There is an increasing demand for platelet transfusions and it remains an ongoing challenge for most blood centers to maintain an adequate platelet inventory. Platelet transfusions doubled in the US and in Can...

    H. Wandt, M. Frank, Th. Denzel, W. Aulitzky, H. Bodenstein in Acute Leukemias VIII (2001)

  2. No Access

    Article

    Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer

    To assess high-dose carboplatin chemotherapy with or without paclitaxel with filgrastim mobilized peripheral blood progenitor cell (PBPC) support in a phase I/II study, a total of 21 patients with mostly chemo...

    H Wandt, J Birkmann, Th Denzel, K Schäfer, G Schwab, D Pilz in Bone Marrow Transplantation (1999)